Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Inflammation in Sepsis
NCT04910464Phase 3Recruiting
- Sponsor
- Assiut University
- Start
- Jun 2021
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in sepsis, sponsored by Assiut University. Started Jun 2021; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04910464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04910464.